ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag academic freedom culture microbiology

bacteria and DNA molecules on a purple background.
Engineering the Microbiome: CRISPR Leads the Way
Mariella Bodemeier Loayza Careaga, PhD | Mar 15, 2024 | 10+ min read
Scientists have genetically modified isolated microbes for decades. Now, using CRISPR, they intend to target entire microbiomes.
Microscopic image of a live amoeba.
Illuminating Specimens Through Live Cell Imaging
Charlene Lancaster, PhD | Mar 14, 2024 | 8 min read
Live cell imaging is a powerful microscopy technique employed by scientists to monitor molecular processes and cellular behavior in real time.
Out, Damned Mycoplasma!
Kelly Rae Chi | Dec 1, 2013 | 8 min read
Pointers for keeping your cell cultures free of mycoplasma contamination
2016 Life Sciences Salary Survey
Karen Zusi | Nov 1, 2016 | 10+ min read
Most researchers feel stimulated by their work but are dissatisfied with their compensation, according to this year’s results.
Of Cells and Limits
Anna Azvolinsky | Mar 1, 2015 | 9 min read
Leonard Hayflick has been unafraid to speak his mind, whether it is to upend a well-entrenched dogma or to challenge the federal government. At 86, he’s nowhere near retirement.
From Classroom to Boardroom
Karen Young Kreeger | Feb 6, 2000 | 6 min read
Some in academia liken it to the world's oldest profession. Others to selling your soul. But when you ask former academics who now work in the business world, switching was the best decision of their professional lives, despite some of the disparaging comparisons their university colleagues may have made. For these researchers--at various stages of their careers, from postdoc to full professor--the lure of the private sector had more to do with finding a suitable career fit than anything
Top 10 Innovations 2015
The Scientist | Dec 1, 2015 | 10+ min read
The newest life-science products making waves in labs and clinics
Anna Johnson-Winegar
Peg Brickley | Nov 10, 2002 | 4 min read
Photo: Courtesy of Anna Johnson-Winegar Two days after anthrax was discovered in a letter addressed to US Sen. Tom Daschle (D-SD), Anna Johnson-Winegar was testifying on the state of the nation's readiness to counter bioterrorism before the Senate Committee on Government Affairs. Her office is the Department of Defense's (DoD) focal point for chemical and biological defense. In the hot seat before the Senate that bright October day, the Pentagon scientist wasted no time trying to convince them
Automated Colony Pickers Evolve
Helen Dell(hdell@the-scientist.com) | Jul 3, 2005 | 6 min read
Everyone knows that the first genome sequencing projects took years of work and represent the combined product of tens of thousands of individual fragments.
Research Notes
Eugene Russo | Jun 25, 2000 | 5 min read
Putting Polio to Good Use Add polio to a host of other viral and bacterial foes that, in modified forms, could prove therapeutically beneficial. Although Russian scientists attempted to use polio to treat cancer in the 1960s--unpublished experiments about which little is known--a recent brain cancer study in mice is the first modern-day attempt to harness the power of the virus (M. Gromeier et al., "Intergeneric poliovirus recombinants for the treatment of malignant glioma," Proceedings of the

Run a Search

ADVERTISEMENT